These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 7884761)
1. A review of the mechanisms of oral tolerance and immunotherapy. Sosroseno W J R Soc Med; 1995 Jan; 88(1):14-7. PubMed ID: 7884761 [TBL] [Abstract][Full Text] [Related]
3. CD4+CD25+ regulatory T-cell therapy for allergy, autoimmune disease and transplant rejection. Jiang S; Lechler RI Inflamm Allergy Drug Targets; 2006 Dec; 5(4):239-42. PubMed ID: 17168794 [TBL] [Abstract][Full Text] [Related]
4. Differences and similarities between sublingual immunotherapy of allergy and oral tolerance. Moingeon P; Mascarell L Semin Immunol; 2017 Apr; 30():52-60. PubMed ID: 28760498 [TBL] [Abstract][Full Text] [Related]
5. Natural and induced regulatory T cells: targets for immunotherapy of autoimmune disease and allergy. Nicolson KS; Wraith DC Inflamm Allergy Drug Targets; 2006 Sep; 5(3):141-8. PubMed ID: 16918477 [TBL] [Abstract][Full Text] [Related]
7. Scientific rationale for the Finnish Allergy Programme 2008-2018: emphasis on prevention and endorsing tolerance. von Hertzen LC; Savolainen J; Hannuksela M; Klaukka T; Lauerma A; Mäkelä MJ; Pekkanen J; Pietinalho A; Vaarala O; Valovirta E; Vartiainen E; Haahtela T Allergy; 2009 May; 64(5):678-701. PubMed ID: 19383025 [TBL] [Abstract][Full Text] [Related]
8. Recombinant allergen and peptide-based approaches for allergy prevention by oral tolerance. Campana R; Huang HJ; Freidl R; Linhart B; Vrtala S; Wekerle T; Karaulov A; Valenta R Semin Immunol; 2017 Apr; 30():67-80. PubMed ID: 28939389 [TBL] [Abstract][Full Text] [Related]
9. Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant bet v 1, the major birch pollen allergen, in a murine model of type I allergy. Wiedermann U; Jahn-Schmid B; Bohle B; Repa A; Renz H; Kraft D; Ebner C J Allergy Clin Immunol; 1999 Jun; 103(6):1202-10. PubMed ID: 10359907 [TBL] [Abstract][Full Text] [Related]
10. Oral tolerance: a biologically relevant pathway to generate peripheral tolerance against external and self antigens. Friedman A; al-Sabbagh A; Santos LM; Fishman-Lobell J; Polanski M; Das MP; Khoury SJ; Weiner HL Chem Immunol; 1994; 58():259-90. PubMed ID: 8011155 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic manipulation of immune tolerance in allergic disease. Akdis M; Akdis CA Nat Rev Drug Discov; 2009 Aug; 8(8):645-60. PubMed ID: 19644474 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies for the therapeutic induction of tolerance. Waldmann H; Qin S; Cobbold SP Immunol Ser; 1993; 59():85-99. PubMed ID: 8461402 [No Abstract] [Full Text] [Related]
13. Potentiation of immunological tolerance induction in adult mice by co-administration of pooled normal IgG and oral tolerogens: a potential therapeutic approach for autoimmune diseases. Mengel J; Fávaro P; Meyer A; Motta V; de Alencar R; Postól E; Cardillo F Med Hypotheses; 2005; 64(5):978-85. PubMed ID: 15780495 [TBL] [Abstract][Full Text] [Related]